Showing results (1581-1590 of 2,048) with videos related to

Sort By:
Pageof 205
JAMA Cardiology|January 9, 2020
Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart FailureGerasimos Filippatos, Christiane E Angermann, John G F Cleland, et al.
The Lancet. Haematology|May 28, 2021
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion studyMehdi Hamadani, Graham P Collins, Paolo F Caimi, et al.
JACC. Heart Failure|September 13, 2024
Inpatient Use of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations Among Community-Based Health SystemsJimmy Zheng, Alexander T Sandhu, Ankeet S Bhatt, et al.
Frontiers in Oncology|May 22, 2014
Human Pancreatic Cancer-Associated Stellate Cells Remain Activated after in vivo ChemoradiationM Carla Cabrera, Estifanos Tilahun, Rebecca Nakles, et al.
The Prostate|May 22, 2014
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsiesLeonard N Chen, Rachel S Rubin, Eugide Othepa, et al.
The Journal of Pathology|November 14, 2008
A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glandsE Chanudet, H Ye, J Ferry, et al.
International Journal of Radiation Oncology, Biology, Physics|September 9, 2020
Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate CancerTrevor J Royce, Panayiotis Mavroidis, Kyle Wang, et al.
Science (New York, N.Y.)|March 21, 2020
Comment on "Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity"Max R Lambert, Molly C Womack, Allison Q Byrne, et al.
British Journal of Haematology|September 14, 2020
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)Adam Gibb, Sarah J Pirrie, Kim Linton, et al.
American Heart Journal|November 4, 2020
Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trialZachary L Cox, Sean P Collins, Mark Aaron, et al.
Pageof 205